Doris Altmann

3.3k total citations
64 papers, 1.4k citations indexed

About

Doris Altmann is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Doris Altmann has authored 64 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 27 papers in Epidemiology and 19 papers in Surgery. Recurrent topics in Doris Altmann's work include Tuberculosis Research and Epidemiology (23 papers), Diagnosis and treatment of tuberculosis (17 papers) and Immunodeficiency and Autoimmune Disorders (16 papers). Doris Altmann is often cited by papers focused on Tuberculosis Research and Epidemiology (23 papers), Diagnosis and treatment of tuberculosis (17 papers) and Immunodeficiency and Autoimmune Disorders (16 papers). Doris Altmann collaborates with scholars based in Germany, Sweden and United States. Doris Altmann's co-authors include Gérard Krause, Walter Haas, Tim Eckmanns, Bonita Brodhun, Birgit Strommenger, Wolfgang Witte, Franziska Layer, Christiane Cuny, Justus Benzler and Klaus Stark and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and Emerging infectious diseases.

In The Last Decade

Doris Altmann

64 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doris Altmann Germany 21 806 483 206 144 133 64 1.4k
Matthew J. Hepburn United States 22 552 0.7× 404 0.8× 276 1.3× 263 1.8× 94 0.7× 49 1.4k
İrfan Şencan Türkiye 22 589 0.7× 385 0.8× 368 1.8× 189 1.3× 65 0.5× 119 1.5k
Läétitia Ninove France 26 1.1k 1.4× 699 1.4× 554 2.7× 169 1.2× 135 1.0× 78 1.8k
Erica Dueger United States 23 648 0.8× 599 1.2× 235 1.1× 79 0.5× 55 0.4× 61 1.5k
Andrew Walker United Kingdom 16 1.3k 1.6× 565 1.2× 183 0.9× 348 2.4× 40 0.3× 28 2.0k
Frederika Dijkstra Netherlands 23 645 0.8× 579 1.2× 341 1.7× 78 0.5× 60 0.5× 57 1.8k
Rachel Civen United States 23 618 0.8× 1.0k 2.2× 393 1.9× 52 0.4× 232 1.7× 38 2.0k
Lucille Blumberg South Africa 26 879 1.1× 718 1.5× 663 3.2× 185 1.3× 420 3.2× 114 2.2k
Melinda Wharton United States 10 637 0.8× 304 0.6× 142 0.7× 99 0.7× 89 0.7× 15 1.2k
Tahaniyat Lalani United States 21 884 1.1× 750 1.6× 363 1.8× 159 1.1× 200 1.5× 88 1.6k

Countries citing papers authored by Doris Altmann

Since Specialization
Citations

This map shows the geographic impact of Doris Altmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Altmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Altmann more than expected).

Fields of papers citing papers by Doris Altmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris Altmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Altmann. The network helps show where Doris Altmann may publish in the future.

Co-authorship network of co-authors of Doris Altmann

This figure shows the co-authorship network connecting the top 25 collaborators of Doris Altmann. A scholar is included among the top collaborators of Doris Altmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris Altmann. Doris Altmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eckmanns, Tim, Benedikt Zacher, Niels Pfennigwerth, et al.. (2022). Geographical differences of carbapenem non-susceptible Enterobacterales and Acinetobacter spp. in Germany from 2017 to 2019. Antimicrobial Resistance and Infection Control. 11(1). 25–25. 4 indexed citations
2.
Diercke, Michaela, et al.. (2020). Implications of a change in case definition and screening of asylum seekers for hepatitis B surveillance in Germany in 2015 and 2016. Epidemiology and Infection. 148. e36–e36. 5 indexed citations
3.
Domaszewska, Teresa, Basel Karo, Christian Kollan, et al.. (2020). Completeness of tuberculosis case notifications in Germany in 2013–2017: first results of an inventory study. BMC Infectious Diseases. 20(1). 766–766. 4 indexed citations
4.
Altmann, Doris, Matthias an der Heiden, Viviane Bremer, et al.. (2020). Evaluation of the German surveillance system for hepatitis B regarding timeliness, data quality, and simplicity, from 2005 to 2014. Public Health. 180. 141–148. 3 indexed citations
5.
Altmann, Doris, et al.. (2019). First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017. PLoS ONE. 14(6). e0217597–e0217597. 27 indexed citations
6.
Brodhun, Bonita, Doris Altmann, Barbara Hauer, Lena Fiebig, & Walter Haas. (2014). Bericht zur Epidemiologie der Tuberkulose in Deutschland für 2013. Robert-Koch-Institut (RKI). 7 indexed citations
7.
Diercke, Michaela, Justus Benzler, I Schöneberg, et al.. (2014). Falldefinitionen für die Surveillance meldepflichtiger Infektionskrankheiten in Deutschland, Ausgabe 2015. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 57(9). 1107–1110. 8 indexed citations
8.
Wilking, Hendrik, Silke Buda, Elena von der Lippe, et al.. (2010). Mortality of 2009 pandemic influenza A(H1N1) in Germany. Eurosurveillance. 15(49). 66 indexed citations
9.
Cuny, Christiane, et al.. (2009). Nasal Colonization of Humans with Methicillin-Resistant Staphylococcus aureus (MRSA) CC398 with and without Exposure to Pigs. PLoS ONE. 4(8). e6800–e6800. 184 indexed citations
10.
Alpers, Katharina, Doris Altmann, Matthias an der Heiden, et al.. (2009). Description of the early stage of pandemic (H1N1) 2009 in Germany, 27 April-16 June 2009. Robert-Koch-Institut (RKI). 6 indexed citations
11.
Jappe, Uta, D Heuck, Birgit Strommenger, et al.. (2008). Staphylococcus aureus in Dermatology Outpatients with Special Emphasis on Community-Associated Methicillin-Resistant Strains. Journal of Investigative Dermatology. 128(11). 2655–2664. 47 indexed citations
12.
Schöneberg, I, Katharina D.C. Stärk, Doris Altmann, & Gérard Krause. (2008). Importierte Malaria in Deutschland - Infektionsländer und Erregerspezies von 1993-2007. Das Gesundheitswesen. 70(4). 256–261. 3 indexed citations
13.
Niedrig, Matthias, Oliver Donoso Mantke, Doris Altmann, & H. Zeller. (2007). First international diagnostic accuracy study for the serological detection of West Nile virus infection. BMC Infectious Diseases. 7(1). 72–72. 35 indexed citations
14.
Schöneberg, I, et al.. (2007). Echinokokkose in Deutschland. MMW - Fortschritte der Medizin. 149(7). 47–47. 1 indexed citations
15.
Haas, Walter, Doris Altmann, & Bonita Brodhun. (2006). Epidemiologie der Tuberkulose im Kindesalter. Monatsschrift Kinderheilkunde. 154(2). 118–123. 2 indexed citations
16.
Krause, Gérard, Bonita Brodhun, Doris Altmann, H. Claus, & Justus Benzler. (2006). Reliability of case definitions for public health surveillance assessed by Round-Robin test methodology. BMC Public Health. 6(1). 129–129. 18 indexed citations
17.
Hauer, B., Bonita Brodhun, Doris Altmann, et al.. (2005). Die Tuberkulosesituation in Deutschland 2001 und 2002. Pneumologie. 59(4). 264–269. 5 indexed citations
18.
Schöneberg, I, Katharina D.C. Stärk, Doris Altmann, & Gérard Krause. (2005). Malaria in Deutschland 1993 bis 2003. DMW - Deutsche Medizinische Wochenschrift. 130(15). 937–941. 10 indexed citations
19.
Hellenbrand, Wiebke, Anette Siedler, Annedore Tischer, et al.. (2003). Progress toward Measles Elimination in Germany. The Journal of Infectious Diseases. 187(s1). S208–S216. 22 indexed citations
20.
Duwe, Susanne, Doris Altmann, Osamah Hamouda, et al.. (2001). Frequency of Genotypic and Phenotypic Drug-Resistant HIV-1 Among Therapy-Naive Patients of the German Seroconverter Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 26(3). 266–273. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew J. Hepburn Breakdown of academic impact, for papers by İrfan Şencan Breakdown of academic impact, for papers by Läétitia Ninove Breakdown of academic impact, for papers by Erica Dueger Breakdown of academic impact, for papers by Andrew Walker Breakdown of academic impact, for papers by Frederika Dijkstra Breakdown of academic impact, for papers by Rachel Civen Breakdown of academic impact, for papers by Lucille Blumberg Breakdown of academic impact, for papers by Melinda Wharton Breakdown of academic impact, for papers by Tahaniyat Lalani
Rankless by CCL
2026